Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time

Key Takeaway: Lantheus Holdings, Inc. announced that it will host a conference call and webcast on February 26, 2025, at 8:00 a.m. ET. The purpose of this event is to discuss the company's financial and operating results for the fourth quarter and the full year of 2024. Participants are encouraged to register ahead of the start time to ensure a smooth experience. The company has a long-standing focus on radiopharmaceuticals, which has been a core aspect of its operations for over 65 years.
Price reaction · baseline $81.92 (2025-02-11 close) · hit after-hours · clean, no other LNTH news in the window
day 0 close
+0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is hosting a conference call to discuss its financial results.
  • The event highlights Lantheus's commitment to transparency with shareholders.
  • Lantheus has a long history of providing radiopharmaceutical solutions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, February 26, 2025, to discuss its financial and operating results for the fourth quarter and full year of 2024.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.

Frequently Asked Questions

When is Lantheus's conference call for Q4 2024 results?

The conference call is scheduled for 8:00 a.m. ET on February 26, 2025.

How can I access the Lantheus conference call?

Participants can register online at the Lantheus investor website.

Will there be a replay of the conference call?

Yes, a replay will be available about two hours after the call.

How long will the replay be accessible?

The replay will be archived for at least 30 days.

What is Lantheus known for?

Lantheus specializes in radiopharmaceutical solutions for better patient outcomes.

Last updated: Feb 12, 2025